Nemonoxacin

DB06600InvestigationalSmall molecule

Investigated for use/treatment in bacterial infection and pneumonia.

Chemical structure of Nemonoxacin
Primary indication
Investigated for use/treatment in bacterial infection and pneumonia.Curator reviewed
Formula / weight
C20H25N3O4 · 371.437 g/mol (avg)
Code names
tg-873870

Resolves to

Compound
UNIIP94L0PVO94CAS378746-64-6ChEMBLCHEMBL1213456ChEBI136053
Clinical / RWD
ATCJ01MB08
Structure
InChIKeyAVPQPGFLVZTJOR-RYUDHWBXSA-NSMILESCOC1=C2N(C=C(C(O)=O)C(=O)C2=CC=C1N1C[C@@H](C)C[C@H](N)C1)C1CC1
Targets
P0A0K8gyrBP20831gyrA

What you can answer from here — as of January 29, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
958Drug interactionsStructured to mechanism, not free text
Sign in
10Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 12 drug categories
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Nemonoxacin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In